![1]()
News
Sotagliflozin use in T2D patients linked with posthospitalization benefits in analysis
June 23, 2021
The paper’s outcome measure may be a meaningful, patient-centered way of capturing disease burden, according to the authors.
News
Prophylactic anticoagulation tied to lower death rate in COVID
June 18, 2021
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.
News
U.S., international MIS-C studies yield disparate results
June 18, 2021
The two real-world observational studies were published online in The New England Journal of Medicine.
News
Reversal agents curb DOAC-related bleeding but deaths still high
June 17, 2021
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
News
AHA: Don’t delay COVID shot while CDC reviews myocarditis cases
June 17, 2021
It remains unclear if suspected myocarditis cases have any direct link to COVID vaccines, and the benefits of vaccination continue to ‘far exceed’ the risks, the AHA says.
News
More obese, diabetic, chronically ill kids hospitalized with COVID-19
June 16, 2021
Children with diabetes, obesity, and cardiac and circulatory congenital anomalies were more likely to be hospitalized with COVID-19 and to be severely ill while hospitalized, a new study finds.
News
Simple risk assessment predicts post-PCI ischemic events
June 15, 2021
Determining if PCI patients have just one or more guideline-based risk features predicts their odds of ischemic events, and can be used to tailor antiplatelet therapy, suggests a real-world analysis.
News
Are left atrial thrombi that defy preprocedure anticoagulation predictable?
June 11, 2021
Features that predispose to such persistent LA thrombi, which are not very rare, could potentially guide more targeted TEE screening before rhythm-control procedures.
News
First risk score to predict bleeding risk after TAVR
June 11, 2021
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
News
Medication in heart failure: Pro tips on therapy with the ‘four pillars of survival’
June 4, 2021
Consider multiple factors when titrating various medications.
